-
Integrating Real-World Evidence Into Oncology HTA Submissions: Recent EU Examples
Sep 9, 2025, 16:22 PM -
Receipt of Biomarker Testing in Non-Small Cell Lung Cancer: Using Real-World Data to Identify Testing Gaps and Treatment Characteristics
Sep 9, 2025, 16:22 PM -
Treatment Patterns, Inadequate Disease Control, and Burden/Unmet Need Among Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Adelphi Real-World Disease Specific Program
Sep 9, 2025, 16:22 PM -
Confidential Prices in NICE Health Technology Assessment: How Common Are They?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Sep 9, 2025, 16:22 PM -
IMF: The Innovative Medicines Fund or the Interim Medicines Fund?
Sep 9, 2025, 16:22 PM -
Assessment of the Economic and Societal Impact of Cervical Cancer Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Evaluating the Repurposing Potential of Statins: Association Between Statin Use and Cognitive Decline in Patients With Mild-to-Moderate Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Real-World Costs of United States Patients With T1 Diabetes, Removing Misdiagnosed Patients, and Compared With Patients With T1D and (T1.5 or T2) Diabetes
Sep 9, 2025, 16:22 PM -
The Role of Qualitative Research in Randomized Controlled Trials Involving Drugs and Medical Devices: A Systematic Mapping Review
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
Understanding Heterogeneity in the Classification of Locally Advanced Cancer: Analysis of Clinical Trial Records From the Past 2 Years (2023-2025)
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Using Site-Specific Wastewater-Based Surveillance to Monitor COVID-19 in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Utilization and Patient Characteristics of Robotic-Assisted Colorectal Surgery in Germany: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Benefit Risk Assessment of Glucagon-Like Peptide 1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta Analysis
Sep 9, 2025, 16:22 PM -
Objective Real-World Caregiver Costs and Lost Time for Absences and Family Medical Leaves in the United States for Employees Whose Spouses Have Dementia and/or Alzheimer’s Disease and Patient Direct Costs
Sep 9, 2025, 16:22 PM -
Viable Reimbursement and Financing Models for mHealth Interventions in Sub-Saharan Africa: A Narrative Review
Sep 9, 2025, 16:22 PM -
Science at PACE? A Multi-Stakeholder Developed Framework for Accelerated Patient Access to Cancer Care
Sep 9, 2025, 16:22 PM -
Integrating CEUS in Diagnostic Pathways: Evidence of Economic and Organizational Sustainability From the Italian Healthcare System
Sep 9, 2025, 16:22 PM -
Evolution of Manufacturer-Set List Prices and GKV Rebates for Orphan Drugs (OD) in Germany 2013-2024: How Much US WAC Is in German OD-Prices
Sep 9, 2025, 16:22 PM